Annual Accounts Payable
$14.63 M
-$3.39 M-18.79%
31 December 2023
Summary:
Akebia Therapeutics annual accounts payable is currently $14.63 million, with the most recent change of -$3.39 million (-18.79%) on 31 December 2023. During the last 3 years, it has fallen by -$26.67 million (-64.57%). AKBA annual accounts payable is now -65.80% below its all-time high of $42.80 million, reached on 31 December 2018.AKBA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$13.49 M
+$3.39 M+33.51%
30 September 2024
Summary:
Akebia Therapeutics quarterly accounts payable is currently $13.49 million, with the most recent change of +$3.39 million (+33.51%) on 30 September 2024. Over the past year, it has increased by +$4.46 million (+49.30%). AKBA quarterly accounts payable is now -79.03% below its all-time high of $64.36 million, reached on 30 September 2019.AKBA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | +49.3% |
| 3 y3 years | -64.6% | -53.2% |
| 5 y5 years | -65.8% | -79.0% |
AKBA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.6% | at low | -59.8% | +49.3% |
| 5 y | 5 years | -65.8% | at low | -79.0% | +49.3% |
| alltime | all time | -65.8% | +3402.0% | -79.0% | +1789.9% |
Akebia Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.49 M(+33.5%) |
| June 2024 | - | $10.11 M(-14.9%) |
| Mar 2024 | - | $11.88 M(-18.8%) |
| Dec 2023 | $14.63 M(-18.8%) | $14.63 M(+61.9%) |
| Sept 2023 | - | $9.04 M(-23.3%) |
| June 2023 | - | $11.78 M(-6.4%) |
| Mar 2023 | - | $12.58 M(-30.2%) |
| Dec 2022 | $18.02 M(-46.3%) | $18.02 M(-8.6%) |
| Sept 2022 | - | $19.71 M(-21.0%) |
| June 2022 | - | $24.94 M(+28.1%) |
| Mar 2022 | - | $19.47 M(-42.0%) |
| Dec 2021 | $33.59 M(-18.7%) | $33.59 M(+16.6%) |
| Sept 2021 | - | $28.81 M(-31.4%) |
| June 2021 | - | $41.98 M(+37.5%) |
| Mar 2021 | - | $30.54 M(-26.1%) |
| Dec 2020 | $41.31 M(+5.3%) | $41.31 M(+2.2%) |
| Sept 2020 | - | $40.40 M(+37.4%) |
| June 2020 | - | $29.41 M(-45.9%) |
| Mar 2020 | - | $54.38 M(+38.7%) |
| Dec 2019 | $39.22 M | $39.22 M(-39.1%) |
| Sept 2019 | - | $64.36 M(+233.1%) |
| June 2019 | - | $19.32 M(+26.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $15.23 M(-64.4%) |
| Dec 2018 | $42.80 M(+511.5%) | $42.80 M(+237.4%) |
| Sept 2018 | - | $12.68 M(+164.5%) |
| June 2018 | - | $4.79 M(-73.2%) |
| Mar 2018 | - | $17.88 M(+155.5%) |
| Dec 2017 | $7.00 M(+243.2%) | $7.00 M(-19.6%) |
| Sept 2017 | - | $8.71 M(-14.8%) |
| June 2017 | - | $10.21 M(-32.3%) |
| Mar 2017 | - | $15.08 M(+639.7%) |
| Dec 2016 | $2.04 M(-11.8%) | $2.04 M(-76.1%) |
| Sept 2016 | - | $8.52 M(+65.7%) |
| June 2016 | - | $5.14 M(+113.0%) |
| Mar 2016 | - | $2.42 M(+4.4%) |
| Dec 2015 | $2.31 M(+14.4%) | $2.31 M(-56.1%) |
| Sept 2015 | - | $5.27 M(+118.6%) |
| June 2015 | - | $2.41 M(-44.3%) |
| Mar 2015 | - | $4.33 M(+114.2%) |
| Dec 2014 | $2.02 M(+183.1%) | $2.02 M(-33.3%) |
| Sept 2014 | - | $3.03 M(+103.7%) |
| June 2014 | - | $1.49 M(-28.4%) |
| Mar 2014 | - | $2.08 M(+190.9%) |
| Dec 2013 | $714.00 K(+70.9%) | $714.00 K |
| Dec 2012 | $417.90 K | - |
FAQ
- What is Akebia Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Akebia Therapeutics?
- What is Akebia Therapeutics annual accounts payable year-on-year change?
- What is Akebia Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly accounts payable year-on-year change?
What is Akebia Therapeutics annual accounts payable?
The current annual accounts payable of AKBA is $14.63 M
What is the all time high annual accounts payable for Akebia Therapeutics?
Akebia Therapeutics all-time high annual accounts payable is $42.80 M
What is Akebia Therapeutics annual accounts payable year-on-year change?
Over the past year, AKBA annual accounts payable has changed by -$3.39 M (-18.79%)
What is Akebia Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AKBA is $13.49 M
What is the all time high quarterly accounts payable for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly accounts payable is $64.36 M
What is Akebia Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AKBA quarterly accounts payable has changed by +$4.46 M (+49.30%)